Scholtz & Company, LLC
- SEC CIK
- 0001606134
- Latest filing
- Aug 11, 2026
DXCM holding history
Dexcom Inc in every 13F filed by Scholtz & Company, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DXCM overviewAll 13F holders of DXCMFull Q2 2026 holdings
- Shares (Q2 2026)
- 77,334
- Value
- $5.21M
- % of portfolio
- 2.6%
- Quarters held
- 10
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 77,334 | $5.21M | 2.6% | +8,686+12.7% | Added | Holders |
| Q1 2026 | 68,648 | $4.31M | 2.2% | +309+0.5% | Added | Holders |
| Q4 2025 | 68,339 | $4.54M | 2.0% | +36,392+113.9% | Added | Holders |
| Q3 2025 | 31,947 | $2.15M | 0.9% | +25,261+377.8% | Added | Holders |
| Q2 2025 | 6,686 | $583.6K | 0.3% | +90+1.4% | Added | Holders |
| Q1 2025 | 6,596 | $450.4K | 0.2% | +6,596 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −25,527−100.0% | Sold out | Holders |
| Q3 2024 | 25,527 | $1.71M | 0.8% | −1,330−5.0% | Reduced | Holders |
| Q2 2024 | 26,857 | $3.05M | 1.3% | +1,059+4.1% | Added | Holders |
| Q1 2024 | 25,798 | $3.58M | 1.6% | +3,259+14.5% | Added | Holders |
| Q4 2023 | 22,539 | $2.80M | 1.4% | +22,539 | New | Holders |